| Kristin Jones, AUD | |
|
22 St Paul Dr Ste 202, Chambersburg, PA 17201 | |
| (717) 217-6870 | |
| (717) 217-6945 |
| Full Name | Kristin Jones |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 8 Years |
| Location | 22 St Paul Dr Ste 202, Chambersburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639527054 | NPI | - | NPPES |
| 103118965 | Medicaid | PA | |
| 13853977 | Other | PA | CAQH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
| Summit Physician Services | 5496659484 | 353 |
News Archive
"During the month of May, USAID's "IMPACTblog" "will be highlighting USAID's work in Global Health," the blog notes, adding, "From May 1-10, we will be featuring the role that science, technology and innovation plays in global health."
A new report, authored in part by researchers at the National Institute of Mental Health (NIMH), part of the National Institutes of Health, provides guidance on how to implement universal suicide risk screening of youth in medical settings.
Peregrine Pharmaceuticals, Inc. today reported positive results from its Phase II trial evaluating bavituximab in combination with docetaxel in patients with advanced breast cancer.
Women choosing repeat cesarean deliveries and having them at term but before completing 39 weeks gestation are up to two times more likely to have a baby with serious complications including respiratory distress resulting in mechanical ventilation and NICU admission.
› Verified 8 days ago
| Provider Name | Summit Physician Services |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1306840814 PECOS PAC ID: 5496659484 Enrollment ID: O20031121000259 |
News Archive
"During the month of May, USAID's "IMPACTblog" "will be highlighting USAID's work in Global Health," the blog notes, adding, "From May 1-10, we will be featuring the role that science, technology and innovation plays in global health."
A new report, authored in part by researchers at the National Institute of Mental Health (NIMH), part of the National Institutes of Health, provides guidance on how to implement universal suicide risk screening of youth in medical settings.
Peregrine Pharmaceuticals, Inc. today reported positive results from its Phase II trial evaluating bavituximab in combination with docetaxel in patients with advanced breast cancer.
Women choosing repeat cesarean deliveries and having them at term but before completing 39 weeks gestation are up to two times more likely to have a baby with serious complications including respiratory distress resulting in mechanical ventilation and NICU admission.
› Verified 8 days ago
| Provider Name | Wellspan Medical Group |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
"During the month of May, USAID's "IMPACTblog" "will be highlighting USAID's work in Global Health," the blog notes, adding, "From May 1-10, we will be featuring the role that science, technology and innovation plays in global health."
A new report, authored in part by researchers at the National Institute of Mental Health (NIMH), part of the National Institutes of Health, provides guidance on how to implement universal suicide risk screening of youth in medical settings.
Peregrine Pharmaceuticals, Inc. today reported positive results from its Phase II trial evaluating bavituximab in combination with docetaxel in patients with advanced breast cancer.
Women choosing repeat cesarean deliveries and having them at term but before completing 39 weeks gestation are up to two times more likely to have a baby with serious complications including respiratory distress resulting in mechanical ventilation and NICU admission.
› Verified 8 days ago
| Provider Name | Tyrone Hospital |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1659472447 PECOS PAC ID: 4183619885 Enrollment ID: O20040420000610 |
News Archive
"During the month of May, USAID's "IMPACTblog" "will be highlighting USAID's work in Global Health," the blog notes, adding, "From May 1-10, we will be featuring the role that science, technology and innovation plays in global health."
A new report, authored in part by researchers at the National Institute of Mental Health (NIMH), part of the National Institutes of Health, provides guidance on how to implement universal suicide risk screening of youth in medical settings.
Peregrine Pharmaceuticals, Inc. today reported positive results from its Phase II trial evaluating bavituximab in combination with docetaxel in patients with advanced breast cancer.
Women choosing repeat cesarean deliveries and having them at term but before completing 39 weeks gestation are up to two times more likely to have a baby with serious complications including respiratory distress resulting in mechanical ventilation and NICU admission.
› Verified 8 days ago
| Provider Name | Wellspan Hearing Center, Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1396404943 PECOS PAC ID: 5698758464 Enrollment ID: O20040611000634 |
News Archive
"During the month of May, USAID's "IMPACTblog" "will be highlighting USAID's work in Global Health," the blog notes, adding, "From May 1-10, we will be featuring the role that science, technology and innovation plays in global health."
A new report, authored in part by researchers at the National Institute of Mental Health (NIMH), part of the National Institutes of Health, provides guidance on how to implement universal suicide risk screening of youth in medical settings.
Peregrine Pharmaceuticals, Inc. today reported positive results from its Phase II trial evaluating bavituximab in combination with docetaxel in patients with advanced breast cancer.
Women choosing repeat cesarean deliveries and having them at term but before completing 39 weeks gestation are up to two times more likely to have a baby with serious complications including respiratory distress resulting in mechanical ventilation and NICU admission.
› Verified 8 days ago
| Provider Name | Ear Nose And Throat Associates Of Central Pa Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1053345397 PECOS PAC ID: 3274832027 Enrollment ID: O20160428001059 |
News Archive
"During the month of May, USAID's "IMPACTblog" "will be highlighting USAID's work in Global Health," the blog notes, adding, "From May 1-10, we will be featuring the role that science, technology and innovation plays in global health."
A new report, authored in part by researchers at the National Institute of Mental Health (NIMH), part of the National Institutes of Health, provides guidance on how to implement universal suicide risk screening of youth in medical settings.
Peregrine Pharmaceuticals, Inc. today reported positive results from its Phase II trial evaluating bavituximab in combination with docetaxel in patients with advanced breast cancer.
Women choosing repeat cesarean deliveries and having them at term but before completing 39 weeks gestation are up to two times more likely to have a baby with serious complications including respiratory distress resulting in mechanical ventilation and NICU admission.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristin Jones, AUD 785 5th Ave Ste 3, Chambersburg, PA 17201-4232 Ph: (717) 263-9555 | Kristin Jones, AUD 22 St Paul Dr Ste 202, Chambersburg, PA 17201 Ph: (717) 217-6870 |
News Archive
"During the month of May, USAID's "IMPACTblog" "will be highlighting USAID's work in Global Health," the blog notes, adding, "From May 1-10, we will be featuring the role that science, technology and innovation plays in global health."
A new report, authored in part by researchers at the National Institute of Mental Health (NIMH), part of the National Institutes of Health, provides guidance on how to implement universal suicide risk screening of youth in medical settings.
Peregrine Pharmaceuticals, Inc. today reported positive results from its Phase II trial evaluating bavituximab in combination with docetaxel in patients with advanced breast cancer.
Women choosing repeat cesarean deliveries and having them at term but before completing 39 weeks gestation are up to two times more likely to have a baby with serious complications including respiratory distress resulting in mechanical ventilation and NICU admission.
› Verified 8 days ago
Easter Seals Central Pa Audiologist Medicare: Not Enrolled in Medicare Practice Location: 55 Hamilton Rd, Chambersburg, PA 17201 Phone: 717-264-1539 | |
Keystone Rural Health Center Audiologist Medicare: Not Enrolled in Medicare Practice Location: 111 Chambers Hill Dr Ste 101, Chambersburg, PA 17201 Phone: 717-709-7997 Fax: 717-261-4725 | |
Kaitlyn Dawes, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 22 St Paul Dr, Chambersburg, PA 17201 Phone: 717-217-6870 | |
Melissa Leigh Kohler, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 111 Chambers Hill Dr Ste 101, Chambersburg, PA 17201 Phone: 717-709-7997 | |
Barry L Deese, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 755 Norland Ave, Suite 202, Chambersburg, PA 17201 Phone: 717-217-6870 Fax: 717-217-6945 | |
Ms. Christine Kay Lindeman, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 755 Norland Avenue, Suite 202, Chambersburg, PA 17201 Phone: 717-217-6870 Fax: 717-217-6945 |